Nanda, K. S., Cheifetz, A. S., & Moss, A. C. (2012). Impact of Antibodies to Infliximab on Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis.
Styl ChicagoNanda, Kavinderjit S., Adam S. Cheifetz, a Alan C. Moss. Impact of Antibodies to Infliximab On Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis. 2012.
Citace podle MLANanda, Kavinderjit S., Adam S. Cheifetz, a Alan C. Moss. Impact of Antibodies to Infliximab On Clinical Outcomes and Serum Infliximab Levels in Patients With Inflammatory Bowel Disease (IBD): A Meta-Analysis. 2012.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..